Pioglitazone for system suitability

About Pioglitazone for system suitability

Pioglitazone for system suitability European Pharmacopoeia (EP) Reference Standard CAS Number 112529-15-4 Empirical Formula (Hill Notation) C19H20N2O3S HCl Molecular Weight 392.90 Synonym: 5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione monohydrochloride, Pioglitazone hydrochloride Properties InChI Key GHUUBYQTCDQWRA-UHFFFAOYSA-N form neat format neat Description Caution Please find SDS provided by EDQM here. . General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . Packaging Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . Biochem/physiol Actions Pioglitazone hydrochloride is a PPAR agonist and thiazolidinedione (TZD) anti-diabetic. Pioglitazone is a selective agonist of the nuclear receptor peroxisome proliferator-activated receptor (PPAR-) and to a lesser extent PPAR-.